The Transition Care Index: Standardizing comprehensive transition and transfer for young adults with inflammatory

Hilary K Michel1,2, Jennifer L Dotson1,2,3,4, Jennie G David1,5

  • 1Department of Pediatrics The Ohio State University College of Medicine Columbus Ohio USA.

JPGN Reports
|August 15, 2025
PubMed

Insights

Implementing the IBD Transition Care Index improved care standardization for young adults with inflammatory bowel disease (IBD) during their transition to adult care. This quality improvement initiative increased the completion of key care variables and multidisciplinary visits.

Area of Science:

  • Quality Improvement in Healthcare
  • Pediatric to Adult Transition of Care
  • Inflammatory Bowel Disease Management

Background:

  • Young adults with inflammatory bowel disease (IBD) face high risks during the transition from pediatric to adult care.
  • Standardizing care and improving preparation are crucial for better outcomes in this vulnerable population.

Purpose of the Study:

  • To implement quality improvement (QI) methods to standardize care for young adults with IBD during their transition to adult services.
  • To decrease care variation and enhance preparation for young adults moving from pediatric to adult IBD care.

Main Methods:

  • Development of the IBD Transition Care Index (TCI), a 10-variable measure assessing comprehensive transition preparation.
  • Education of patients, caregivers, and providers on TCI completion and its importance.
  • Systematic recording and regular review of TCI variable completion rates.

Main Results:

  • The mean percentage of TCI variables completed increased from 62% to 71% post-intervention.
  • A significant increase in multidisciplinary IBD annual visit attendance was observed (51% vs. 62%).
  • Patients under general gastroenterology physicians showed significant improvements in TCI completion and annual visit attendance.

Conclusions:

  • Care Indexes like the TCI can effectively reduce variability and standardize the complex transition process for young adults with IBD.
  • Standardization of care through tools like the TCI aims to ultimately improve patient outcomes in IBD transition.
Abstract

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
420
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
383
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
189
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
213
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
324
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
237